
AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Enpro today, you need to be comfortable with a company investing through cyclical end markets while managing recent margin pressure and a low return on equity. The latest valuation concerns, including third party flags of potential downside and a relative “Hold” ranking, sharpen the near term focus on price risk but do not materially change the core catalyst, which remains execution on growth initiatives without further profit compression.
The recent phantom stock grants to non employee directors matter here because they reinforce board exposure to the same share price volatility that investors face, at a time when external models see Enpro as expensive versus both intrinsic value estimates and machinery peers. That alignment sits alongside management’s ongoing push to grow revenue and earnings, where any misstep on costs or acquisition execution could weigh more heavily if sentiment turns against a richly priced stock.
Yet investors should also be aware that if cyclical end markets weaken further, the combination of high valuation and profit volatility could...
Read the full narrative on Enpro (it's free!)
Enpro's narrative projects $1.5 billion revenue and $322.2 million earnings by 2029.
Uncover how Enpro's forecasts yield a $327.00 fair value, a 3% downside to its current price.
One member of the Simply Wall St Community currently pegs Enpro’s fair value at US$327 per share, against a recent market price that is higher. You can compare that single viewpoint with the valuation warnings and cyclical end market risks discussed above to see how differently investors can frame Enpro’s future performance.
Explore another fair value estimate on Enpro - why the stock might be worth just $327.00!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com